[1] Haddad RI, Bischoff L, Ball D, et al.  Thyroid carcinoma, version 2.2022, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2022, 20(8): 925-951.   doi: 10.6004/jnccn.2022.0040
[2] Yang GCH, LiVolsi VA, Baloch ZW.  Thyroid microcarcinoma: fine-needle aspiration diagnosis and histologic follow-up[J]. Int J Surg Pathol, 2002, 10(2): 133-139.   doi: 10.1177/106689690201000206
[3] Boucek J, Kastner J, Skrivan J, et al.  Occult thyroid carcinoma[J]. Acta Otorhinolaryngol Ital, 2009, 29(6): 296-304.
[4]

Liu H, Lv L, Yang K. Occult thyroid carcinoma: a rare case report and review of literature[J/OL]. Int J Clin Exp Pathol, 2014, 7(8): 5210-5214[2022-11-28]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4152089.
[5] Herbowski L, Dobrzycki W.  Incidental detection of unexpected neck lymphatic Ⅲ level node metastasis from occult papillary thyroid carcinoma during cervical disc surgery: first literature report[J]. Endokrynol Pol, 2020, 71(4): 361-362.   doi: 10.5603/EP.a2020.0031
[6] Dong P, Chen N, Li L, et al.  An upper cervical cord compression secondary to occult follicular thyroid carcinoma metastases successfully treated with multiple radioiodine therapies: a clinical case report[J]. Medicine (Baltimore), 2017, 96(41): e8215-.   doi: 10.1097/MD.0000000000008215
[7]

Baião JM, Guimarães A, Moreira N, et al. Acute paraparesis as presentation of an occult follicular thyroid carcinoma: a case report[J/OL]. Int J Surg Case Rep, 2017, 41: 498-501[2022-11-28]. https://www.sciencedirect.com/science/article/pii/S2210261217306235?via%3Dihub. DOI: 10.1016/j.ijscr.2017.11.045.
[8] Jha CK, Agrawal V, Mishra A, et al.  Overt skeletal metastases in a patient of occult (Microscopic) follicular thyroid carcinoma: a rare case[J]. Indian J Surg Oncol, 2018, 9(1): 68-70.   doi: 10.1007/s13193-017-0709-3
[9] Xu B, Scognamiglio T, Cohen PR, et al.  Metastatic thyroid carcinoma without identifiable primary tumor within the thyroid gland: a retrospective study of a rare phenomenon[J]. Hum Pathol, 2017, 65: 133-139.   doi: 10.1016/j.humpath.2017.05.013
[10]

Yamashita G, Kondo T, Okimura A, et al. Occult papillary thyroid carcinoma without detection of the primary tumor on preoperative ultrasonography or postoperative pathological examination: a case report[J/OL]. Case Rep Oncol, 2020, 13(1): 105−112[2022-11-28]. https://karger.com/cro/article/13/1/105/95324/Occult-Papillary-Thyroid-Carcinoma-without. DOI: 10.1159/000505831.
[11] 中国临床肿瘤学会指南工作委员会.  中国临床肿瘤学会(CSCO)分化型甲状腺癌诊疗指南 2021[J]. 肿瘤预防与治疗, 2021, 34(12): 1164-1201.   doi: 10.3969/j.issn.1674-0904.2021.12.013
Guidelines Working Committee of Chinese Society of Clinical Oncology.  Guidelines of Chinese Society of Clinical Oncology (CSCO) differentiated thyroid cancer[J]. J Cancer Control Treat, 2021, 34(12): 1164-1201.   doi: 10.3969/j.issn.1674-0904.2021.12.013
[12] 谭建.  靶向药物治疗分化型甲状腺癌进入新时代[J]. 中华核医学与分子影像杂志, 2022, 42(11): 641-643.   doi: 10.3760/cma.j.cn321828-20220907-00281
Tan J.  A new era for targeted drug treatment of differentiated thyroid cancer is arriving[J]. Chin J Nucl Med Mol Imaging, 2022, 42(11): 641-643.   doi: 10.3760/cma.j.cn321828-20220907-00281